On September 1, 2022 Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, reported that the Company will be participating in and hosting one-on-one meetings at the following conferences during September (Press release, Aadi Bioscience, SEP 1, 2022, View Source [SID1234618894]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 17th Annual BioPharma Conference, September 7-8, 2022, in Boston, MA
Morgan Stanley’s 20th Annual Global Healthcare Conference, September 12-14, 2022, in New York, NY
Neil Desai, Ph.D., Aadi Bioscience Founder and CEO, will take part in a 30-minute fireside chat on Wednesday, September 14th at 2:55 pm ET
A live webcast of the fireside chat will be available on the Investors & News page of the Company’s website
H.C. Wainwright’s 24th Annual Global Investment Conference, September 12-14, 2022, in New York, NY
A pre-recorded presentation will be available on the Investors & News page of the Company’s website on Monday, September 12 at 7:00 am ET
Ladenburg Thalmann’s 2022 Healthcare Conference, September 29, 2022, in New York, NY
Neil Desai, Ph.D., Aadi Bioscience Founder and CEO, will give a brief presentation followed by an analyst-led fireside chat from 9:00 am – 9:25 am ET
A live webcast of the presentation will be available on the Investors & News page of the Company’s website
Replays of webcasts will be available for approximately 30 days following each presentation.